Price
Target price
€68.40
€68.40
-1.660%
-1.14
-1.660%
€124.85
28.11.25 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
A loss of -1.660% shows a downward development for Corcept Therapeutics Inc..
Corcept Therapeutics Inc. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 124 € shows a very positive potential of 81.29% compared to the current price of 68.4 € for Corcept Therapeutics Inc..
For the coming years our community has positive and negative things to say abot the Corcept Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | -1.660% | 1.937% | 11.364% | 23.243% | 37.322% | 178.502% | 252.577% |
| Pacira Pharmaceuticals | - | 4.124% | 11.602% | 31.169% | 9.189% | -56.466% | -61.524% |
| Rockwell Medical Inc. | 4.660% | 11.240% | -14.592% | -60.707% | -59.499% | -18.350% | -91.003% |
| Twist Bioscience Corp | 0.590% | 11.214% | -4.898% | -39.659% | -39.711% | 13.785% | -71.723% |
Comments
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat